Zeng Qingjing, Yan Ronghua, Zhang Lanxia, Yu Xuan, Wu Yuxuan, Zheng Rongqin, Xu Erjiao, Li Kai
The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Peking University Shenzhen Hospital, Shenzhen, China.
Abdom Radiol (NY). 2025 Jun;50(6):2512-2521. doi: 10.1007/s00261-024-04724-8. Epub 2024 Nov 30.
To evaluate the feasibility and efficiency between the two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration for US-CT/MR fusion imaging of liver tumours.
From May 2017 to December 2017, 30 patients with 30 liver tumours were enrolled in this prospectively study. Two intelligent auto-registrations (based on hepatic vessels or based on liver surface) and manual registration were randomly performed, the registration success rate and efficiency were compared.
In terms of success rate, auto-registrations based on the hepatic vessels (80%) was lower than auto-registration base on liver surface and manual registration (96.67%), but with no statistical difference (P = 0.125). In comparison of the registration efficiency, the efficiency of the auto-registration based on the hepatic vessels was superior to auto-registration based on liver surface and manual registration (P < 0.05). The one-step success rate of auto-registration based on the hepatic vessels (53.33%, 16/30) was higher than that of other two registrations (P < 0.05). Stratified analysis showed that, for the lesion with display of hepatic vessels in grade 3, the success rate of auto-registration based on vessels (0%) was lower than that of auto-registration based on liver surface and manual registration (100%) (P = 0.031).
Intelligent auto-registration based on hepatic vessels is a feasible and efficient registration method for US-CT/MR fusion imaging of liver tumours for the patients with clear hepatic vessels. The auto-registration based on liver surface and manual registration can be an effective supplement for cases with poor hepatic vessels display.
评估两种智能自动配准方法(基于肝血管或基于肝脏表面)与手动配准在肝脏肿瘤US-CT/MR融合成像中的可行性和效率。
2017年5月至2017年12月,30例患有30个肝脏肿瘤的患者纳入本前瞻性研究。随机进行两种智能自动配准(基于肝血管或基于肝脏表面)和手动配准,比较配准成功率和效率。
在成功率方面,基于肝血管的自动配准(80%)低于基于肝脏表面的自动配准和手动配准(96.67%),但无统计学差异(P = 0.125)。在配准效率比较中,基于肝血管的自动配准效率优于基于肝脏表面的自动配准和手动配准(P < 0.05)。基于肝血管的自动配准一步成功率(53.33%,16/30)高于其他两种配准(P < 0.05)。分层分析显示,对于肝血管显示为3级的病变,基于血管的自动配准成功率(0%)低于基于肝脏表面的自动配准和手动配准(100%)(P = 0.031)。
对于肝血管清晰的患者,基于肝血管的智能自动配准是肝脏肿瘤US-CT/MR融合成像的一种可行且有效的配准方法。基于肝脏表面的自动配准和手动配准可为肝血管显示不佳的病例提供有效补充。